about
Role of imaging techniques in the diagnosis of dementia11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will playSensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaMR-less surface-based amyloid assessment based on 11C PiB PET11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairmentBiomarkers of Alzheimer's diseaseUntangling tau imagingToward precision medicine in Alzheimer's diseaseWhat can imaging tell us about cognitive impairment and dementia?Drug Development in Alzheimer's Disease: The Contribution of PET and SPECTAre Anxiety Disorders Associated with Accelerated Aging? A Focus on NeuroprogressionInsight into the Molecular Imaging of Alzheimer's DiseaseAlzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkersClinical molecular imaging with radiotracers: current statusPreclinical Alzheimer disease: identification of cases at risk among cognitively intact older individualsAmyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's diseaseDevelopment of positron emission tomography β-amyloid plaque imaging agentsMild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's diseaseqPR: An adaptive partial-report procedure based on Bayesian inference.18F-florbetaben Aβ imaging in mild cognitive impairmentThe Eye As a Biomarker for Alzheimer's DiseaseBeta-amyloid deposition and the aging brainPrediction of cognitive decline in healthy older adults using fMRIFunctional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease riskDifferences in functional brain connectivity alterations associated with cerebral amyloid deposition in amnestic mild cognitive impairmentAmyloid is linked to cognitive decline in patients with Parkinson disease without dementiaRemoving obstacles in neuroscience drug discovery: the future path for animal models.Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadePET amyloid-beta imaging in preclinical Alzheimer's diseaseThe mismatch negativity as an index of cognitive decline for the early detection of Alzheimer's diseaseIn vivo assessment of amyloid-β deposition in nondemented very elderly subjectsClassification of amyloid-positivity in controls: comparison of visual read and quantitative approaches.Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia.Amyloid imaging in dementias with atypical presentation.Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study.Abeta amyloid and glucose metabolism in three variants of primary progressive aphasiaDisruption of functional connectivity in clinically normal older adults harboring amyloid burden.The role of hippocampal iron concentration and hippocampal volume in age-related differences in memory.
P2860
Q22241579-7290D0D2-62B4-4BA3-B57B-A37A5FBDFA55Q24194742-76FD1F16-E755-4068-A6CB-D59370930722Q24201039-64C9BB9E-5FE9-49B5-9774-CCEB5D81ABCDQ24594531-9432B152-E497-469A-A42F-27B745892A34Q24598142-E9B44329-3EC8-4789-B111-52E128ADF942Q24618963-6162338D-89BF-4447-B2BD-CDDD35E063F4Q24648319-915863D2-092C-4A53-B017-30FA7EB7E765Q24650667-FBF22C5F-E022-4D5A-8E1B-50002EFCB7F6Q26739091-03711F04-2308-4CAF-8D94-CEBA1F111B4EQ26748939-FA9B73E9-7AD1-4A0D-9E5C-A79282537D16Q26749292-F41B73AB-9763-4664-A285-69C46D2C3419Q26749755-42E0445A-395D-4D1F-BABA-EB8F32174202Q26765559-380B036E-593D-4650-8A7E-0889F7EC3322Q26765945-DFC7D895-8530-447E-A6E8-C958B63290E9Q26825442-B64C65FB-93E2-41DA-A2B3-0363D619CFF2Q26994741-FBE1278B-A26D-4ED1-9701-986FB7E38BB3Q26995405-7238901C-6DC6-4551-8AF6-BAABF26E1D6DQ27009411-B6960EF5-B062-456E-AF23-7A66F4D7953CQ27012742-AE554394-C4F7-42E9-A300-45CEE70CDC9FQ27027319-1C0E3C74-A152-4D65-8BC4-2E26E45374EEQ27335564-60EFF86B-3014-4241-A6C7-95F9EB996BF6Q27499311-382F8644-4A2B-4510-A6DB-A0FEA4061DA0Q28070142-780810FC-2B08-4C56-956E-F56206C7127DQ28264556-C6ACE0FC-8A0A-4A2C-B412-F9A9CEA3F0BEQ28383378-3C7214B7-8794-4825-A5AD-62E66B665CFDQ28394799-4B644D90-EB63-49F6-965A-87A6E6850BA8Q28649713-D780FEB7-49C2-44A3-8A27-0AC069649013Q28705235-6736A26A-AB8B-421D-B33B-0DFF9CE681F3Q28755229-45925B18-0298-4D28-8372-D58F0C2F7368Q29614407-B81B9EC8-69B1-4805-9A1F-116040B9FADEQ30040695-84AE1FA5-81FA-448F-8C7C-6C35E584F997Q30374343-63C1D537-76D4-4FE3-8BF3-C3F8890BCC34Q30412704-8F04355B-7EE6-450C-9326-A688BB786259Q30413572-245F592A-9D2A-43BA-9463-E8B1D213FEABQ30413904-C67EDAB2-66F2-4E30-8C93-3F7056325052Q30417342-5CFF5C68-96F3-4526-9811-C0A710276679Q30422060-E23AAF9B-F1AA-4BBD-8EEB-0B972CF58B7DQ30486197-FD58BC7C-90E0-487D-B94F-270EA9F2C606Q30492809-A85F2E43-BBE5-40DF-BFE7-6C3F138FFB5CQ30540311-8BC23FB2-6012-40DE-917F-D54D2B9FCCA5
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Imaging beta-amyloid burden in aging and dementia.
@en
Imaging beta-amyloid burden in aging and dementia.
@nl
type
label
Imaging beta-amyloid burden in aging and dementia.
@en
Imaging beta-amyloid burden in aging and dementia.
@nl
prefLabel
Imaging beta-amyloid burden in aging and dementia.
@en
Imaging beta-amyloid burden in aging and dementia.
@nl
P2093
P50
P1433
P1476
Imaging beta-amyloid burden in aging and dementia
@en
P2093
Ackermann U
Dickinson KL
Masters CL
P304
P356
10.1212/01.WNL.0000261919.22630.EA
P407
P577
2007-05-01T00:00:00Z